TREVICTA PALIPERIDONE 263MG INJECTION

Trevicta (generic name: paliperidone palmitate) is an injectable antipsychotic medication primarily used for the treatment of schizophrenia in adults. It is a long-acting formulation of paliperidone, which is an active metabolite of risperidone. Trevicta is administered as an intramuscular injection, typically once every three months, making it a convenient option for patients who may have difficulty adhering to daily oral medication regimens.

The drug works by modulating the effects of neurotransmitters in the brain, particularly dopamine and serotonin, which are believed to play a key role in the symptoms of schizophrenia. By stabilizing these neurotransmitter levels, Trevicta helps reduce the severity of psychotic symptoms such as hallucinations, delusions, and disorganized thinking. Additionally, it may also be used in some cases for the treatment of schizoaffective disorder. Regular monitoring by healthcare professionals is essential during treatment.